Literature DB >> 32342306

Obtaining and Characteristic of Antibodies to Vibrio cholerae Protective Antigens Conjugated with Gold Nanoparticles.

L A Dykman1, O A Volokh2, O V Gromova2, O S Durakova2, S A Vorobeva2, M N Kireev2, L F Livanova2, A K Nikiforov2, S Y Shchyogolev3, V V Kutyrev2.   

Abstract

Gold nanoparticle conjugates with Vibrio cholerae antigens were synthesized. The animals were immunized with the obtained conjugates. Rabbit polyclonal antibodies to the antigens were obtained, which showed high specific activity. On the model of white laboratory mice, the protective activity of conjugates of cholera antigens with nanoparticles during infection of vaccinated animals was evaluated using a commercial vaccine as a control. It was shown that in terms of immunogenicity, the created prototypes of cholera vaccine using gold nanoparticles as a carrier and adjuvant complied with the production regulations for the Russian national cholera chemical vaccine.

Entities:  

Keywords:  Vibriocholerae; gold nanoparticles; immunization; vaccination

Year:  2020        PMID: 32342306     DOI: 10.1134/S1607672920010068

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  10 in total

1.  [Perfection of methodical approaches to designing vaccines against tick-borne encephalitis].

Authors:  V A Demenev; M A Shchinova; L I Ivanov; R N Vorob'eva; N I Zdanovskaia; N V Nebaĭkina
Journal:  Vopr Virusol       Date:  1996 May-Jun

Review 2.  Immunological basis for enhanced immunity of nanoparticle vaccines.

Authors:  Hannah G Kelly; Stephen J Kent; Adam K Wheatley
Journal:  Expert Rev Vaccines       Date:  2019-02-14       Impact factor: 5.217

3.  Metallic Nanoparticles for Cancer Immunotherapy.

Authors:  Emily Reiser Evans; Pallavi Bugga; Vishwaratn Asthana; Rebekah Drezek
Journal:  Mater Today (Kidlington)       Date:  2017-12-14       Impact factor: 31.041

Review 4.  Advances and Opportunities in Nanoparticle- and Nanomaterial-Based Vaccines against Bacterial Infections.

Authors:  Leon Chien-Wei Lin; Saborni Chattopadhyay; Jung-Chen Lin; Che-Ming Jack Hu
Journal:  Adv Healthc Mater       Date:  2018-03-06       Impact factor: 9.933

5.  Gold nanoparticles as an adjuvant: Influence of size, shape, and technique of combination with CpG on antibody production.

Authors:  Lev A Dykman; Sergey A Staroverov; Alexander S Fomin; Vitaly A Khanadeev; Boris N Khlebtsov; Vladimir A Bogatyrev
Journal:  Int Immunopharmacol       Date:  2017-11-14       Impact factor: 4.932

Review 6.  The golden age: gold nanoparticles for biomedicine.

Authors:  Erik C Dreaden; Alaaldin M Alkilany; Xiaohua Huang; Catherine J Murphy; Mostafa A El-Sayed
Journal:  Chem Soc Rev       Date:  2011-11-22       Impact factor: 54.564

7.  A new method for producing a specific and high titre antibody against glutamate using colloidal gold as a carrier.

Authors:  S Shiosaka; H Kiyama; A Wanaka; M Tohyama
Journal:  Brain Res       Date:  1986-09-24       Impact factor: 3.252

8.  Immunological properties of gold nanoparticles.

Authors:  Lev A Dykman; Nikolai G Khlebtsov
Journal:  Chem Sci       Date:  2016-11-16       Impact factor: 9.825

Review 9.  Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines.

Authors:  Sónia Alexandra Correia Carabineiro
Journal:  Molecules       Date:  2017-05-22       Impact factor: 4.411

10.  Cholera: Immunity and Prospects in Vaccine Development.

Authors:  Jason B Harris
Journal:  J Infect Dis       Date:  2018-10-15       Impact factor: 5.226

  10 in total
  2 in total

1.  Selenium Nanoparticles Induce Potent Protective Immune Responses against Vibrio cholerae WC Vaccine in a Mouse Model.

Authors:  Zahra Raahati; Bita Bakhshi; Shahin Najar-Peerayeh
Journal:  J Immunol Res       Date:  2020-12-30       Impact factor: 4.818

Review 2.  Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases.

Authors:  Lev A Dykman
Journal:  Expert Rev Vaccines       Date:  2020-04-28       Impact factor: 5.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.